Thorac Cardiovasc Surg 2012; 60(05): 360-362
DOI: 10.1055/s-0031-1295565
Short Communication
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Low-Volume, Single-Shot Crystalloid Cardioplegia is Safe for Isolated Aortic Valve Replacement

Authors

  • Peter Matt

    1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
    *   These authors contributed equally to this work
  • Emilio Arbeleaz

    1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
    *   These authors contributed equally to this work
  • Goetz Schwirtz

    1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
  • Thomas Doebele

    1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
  • Friedrich Eckstein

    1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
Further Information

Publication History

12 January 2011

21 July 2011

Publication Date:
29 December 2011 (online)

Abstract

We report our experience with a low-volume (100 mL), single-shot crystalloid cardioplegia (Cardioplexol) in 61 consecutive patients undergoing isolated aortic valve replacement (AVR). Cardioplexol resulted in immediate cardiac arrest. Intraoperative courses were uneventful. Postoperative markers of myocardial damage, Troponin T and CK-MB levels, were low but steadily increased with longer cross-clamp time. Thirty-day mortality was 3% and all noncardiac. Cardioplexol not only simplifies and speeds up the procedure but also seems to be safe for patients undergoing AVR.